Amanote Research

Amanote Research

    RegisterSign In

Estimating Prevalence of Prostate Cancer Clinical States Using a Dynamic Patient Progression Model

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.428
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

November 1, 2013

Authors
R.N. DassP. Wheatley PriceR. GooseyM. SpencerC. PrützG. AhlgrenA. BerrutiD. FordP. HambergJ. KlierM.J. RibalD. SchrijversJ.M. WolffA. Durand
Publisher

Elsevier BV


Related search

Prevalence of Prostate Cancer Clinical States and Mortality in the United States: Estimates Using a Dynamic Progression Model

PLoS ONE
Multidisciplinary
2015English

Molecular Model for Neuroendocrine Prostate Cancer Progression

BJU International
Urology
2018English

Molecular Profiling of Prostate Cancer Progression

Nature Genetics
Genetics
2001English

Molecular Mechanisms of Prostate Cancer Progression

2005English

Molecular Pathogenesis and Progression of Prostate Cancer

Seminars in Oncology
OncologyHematology
2013English

Stat3 Promotes Metastatic Progression of Prostate Cancer

American Journal of Pathology
Forensic MedicinePathology
2008English

Deregulation of FOXO3A During Prostate Cancer Progression

International Journal of Oncology
Cancer ResearchOncology
2009English

Glipizide Suppresses Prostate Cancer Progression in the TRAMP Model by Inhibiting Angiogenesis

Scientific Reports
Multidisciplinary
2016English

Thromboxane Synthase and Prostate Cancer Progression

2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy